The ob gene product, leptin, apparently exclusively expressed in adipose tissue, is a signaling factor regulating body weight homeostasis and energy balance. ob gene expression is increased in obese rodents and regulated by feeding, insulin, and glucocorticoids, which supports the concept that ob gene expression is under hormonal control, which is expected for a key factor controlling body weight homeostasis and energy balance. In humans, ob mRNA expression is increased in gross obesity; however, the effects of the above factors on human ob expression are unknown. We describe the structure of the human ob gene and initial functional analysis of its promoter. The human ob gene's three exons cover "15 kb of genomic DNA. The entire coding region is contained in exons 2 and 3, which are separated by a 2-kb intron. The first small 30-bp untranslated exon is located >10.5 kb upstream of the initiator ATG codon. Three kilobases ofDNA upstream of the transcription start site has been cloned and characterized. Only 217 bp of 5' sequence are required for basal adipose tissue-specific expression of the ob gene as well as enhanced expression by C/EBPc. Mutation of the single C/EBPa site in this region abolished inducibility of the promoter by C/EBPa in cotransfection assays. The gene structure will facilitate our analysis ofob mutations in human obesity, whereas knowledge of sequence elements and factors regulating ob gene expression should be of major importance in the prevention and treatment of obesity.
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Obesity, a disorder of energy balance, is a major health problem in Western societies, linked to cardiovascular disease, diabetes and an increased mortality rate (1) . The description of six single-gene mutations resulting in obesity in mice is consistent with the implication of genetic factors in the etiology of obesity (2) . In the obese (ob) mouse, a single mutation results in profound obesity which is often accompanied by diabetes (3) . This phenotype results from both a marked hyperphagia and a decrease in energy expenditure. Parabiosis experiments have suggested that ob mice are deficient of a blood-borne factor regulating nutrient intake and energy metabolism (4) . By using positional cloning techniques, the mouse ob gene, and its human homologue, which is highly similar to the mouse gene, have been cloned (5) . The mutant SM/Ckc-+Dacob2J/ob2J mouse carries a genomic alteration that results in the complete absence of ob mRNA, whereas in C57BL/6J-ob/ob mice a nonsense mutation results in a truncated, nonfunctional protein. The ob gene is expressed in adipose tissue, and its mRNA contains a signal sequence. Studies with specific antibodies confirmed the presence of the ob gene product, leptin, in the plasma of normal mice and its absence in the plasma of ob/ob mutants (6) . Three groups (6) (7) (8) independently confirmed that leptin reduces food intake, increases energy expenditure, induces weight loss, and normalizes metabolic parameters such as insulin and glucose when injected in wild-type, diet-induced obese mice or C57BL/6J ob/ob mice. Recent studies demonstrated that the expression of the ob gene itself is controlled by the nutritional status of the animal. Fasting reduces expression, whereas food intake increases expression (9) (10) (11) (12) , an effect that is accounted for by changes in insulin levels (10, 11) . Glucocorticoids have also been shown to regulate ob gene expression (13, 14) .
Because ob is exclusively expressed in adipocytes, we have initiated a series of studies to examine the role of adipogenic factors in the expression and regulation of the ob gene. The expression of two important adipocyte transcription factors, PPARy and C/EBPa, is induced during adipocyte differentiation, and these factors are maintained in the mature adipocyte. Several adipocyte specific genes have binding sites for these factors and have been shown to be transcriptionally responsive to chemical modulators of these factors (reviewed in ref. 15) .
To better understand the role of leptin in the development of human obesity, it is crucial that we gain insight into the regulation of ob gene expression in humans. Therefore, we have determined the structure of the human ob gene and studied its regulation in two different adipocyte model systems. In these studies we used primary rat adipocytes as a model of fully differentiated adipocytes (16) and the mouse 3T3-L1 cell line as a preadipocyte model. Our results demonstrate that 217 bp of DNA upstream of the transcription start site controls basal and tissue-specific ob gene expression. Furthermore, this region contains a sequence element which responds to C/EBPa, a key transcription factor implicated in the determination of the adipocyte phenotype, as well as other potential regulatory sites.
MATERIALS AND METHODS
Oligonucleotides. The oligonucleotides used for various aspects in this manuscript are as follows (N1 = G, A, or C, whereas N = G, A, C, or T): 1F, 5 '-ATG CAT TGG GGA  ACC CTG TGC GG-3'; 140R, 5'-TGT GAA ATG TCA TTG  ATC CTG GTG ACA ATT-3'; 217R, 5'-GAGGGTTTTG-GTGTCATCTTGGAC-3'; 562R, 5'-CCTGCTCAGGGC-CACCACCTCTGTCG-3'; anchored-T, 5'-TTCTAGAATT-CAGCGGCCGC(T) $To whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Primer extension. The oligonucleotide pdv34R was 32p_ labeled to a specific activity of 107 dpm/50 ng and purified by gel electrophoresis. For primer extension, 105 dpm of oligonucleotide was added to 50 ,ug of adipose tissue total RNA from different patients in a final volume of 100 ,lI. Primer extension analysis was performed following standard protocols utilizing a mixture of 1.25 units of avian myeloblastosis virus reverse transcriptase (BRL) and 100 units of Moloney murine leukemia virus reverse transcriptase (BRL). A sequencing reaction and molecular mass standards were used to map the 5' end of the extension products.
Si analysis. A 5' 32P-labeled, gel-purified oligonucleotide probe OB/Si (50,000 cpm) was annealed (14 hr, 30°C) to 50 ,ug adipose tissue total RNA from different subjects in 20 ,ul of hybridization buffer. A 10 ,ul aliquot of the annealing reaction was subjected to S1 nuclease digestion according to the manufacturer's protocol (Ambion, Austin, TX), and the reaction products were analyzed on a 10% denaturing gel. A 35S-labeled 10-nucleotide ladder was used as a size standard.
Tissue Samples, Cell Culture, and mRNA Analysis. Omental adipose tissue was obtained from overnight fasted nonobese adult French subjects undergoing elective surgery. They had given informed consent, and the project was approved by the Ethics Committee of the University of Lille. Adipose tissue was immediately frozen in liquid nitrogen until RNA preparation.
Primary rat adipocytes were obtained exactly as described by Hajduch et al. (17) . Standard cell culture conditions were used to maintain 3T3-L1 (American Type Culture Collection), CV-1 (a kind gift from R. Evans, Salk Institute, La Jolla, CA), and COS cells (American Type Culture Collection). RNA preparation, Northern blot hybridizations, and quantification of total cellular RNA were performed as described (11) . A mouse ob cDNA fragment spanning nucleotides +50 to +659 (13) , a human GAPDH cDNA clone (18) , and a human y-actin (19) (20) .
Transfections were performed by using either standard calcium phosphate precipitation techniques (21) or electroporation for primary adipocytes (16) . Luciferase assays were carried out exactly as described (21) . pGL3-Basic and pGL3-Control (Promega) were used as transfection controls for comparison across the cell lines. Relative expression of the pGL3-OB plasmids in pre-adipocytes was several fold lower than the primary adipocytes (raw luciferase values of '5000 versus -25,000 in a comparable assay) and the data are presented as relative levels within a given cell type.
RESULTS
Characterization of the Transcription Initiation Site of the Human ob Gene. Recent work has characterized the cDNA for the human ob gene (22) . To unambiguously map the 5' end of the cDNA, several approaches were undertaken. First, 5'-RACE was performed, which generated four independent clones using two different sources of human adipose tissue RNA as starting material. Three additional independent 5'-RACE products were obtained with adipose tissue cDNA purchased from Clontech. All seven 5'-RACE products contained an identical sequence that extended up to 46 bp 5' to the ATG codon, whereas a single clone was 2 bp longer (Fig. 1) . Next, primer extension experiments were performed by using four independent human adipose tissue RNA samples. Two major extension products of 94 and 91 bp were observed with the pdv34R primer. The longest extension product was 9 nucleotides longer than the longest 5'-RACE clone (Fig. 1) . Finally, we mapped the start site of the mRNA by using the S1 nuclease protection assay. This method confirmed the most 5' start site as identified by primer extension assay (Fig. 1) distributed over -15 kb of genomic DNA. The entire coding sequence is contained in exons 2 and 3, which are separated by a 2-kb intron. The first exon, comprising only the 5'-untranslated sequence, is 30 bp (located 10.5 kb upstream of the second exon), which contains the initiator ATG (Fig. 1) .
Tissue-Specific Determinants of the Human ob Promoter. Previous studies suggested that the expression of the ob mRNA is specific for adipose tissue and strongly regulated in rodents (9) (10) (11) (12) (13) (14) . We subcloned the region 5' to the transcription initiation site and sequenced the proximal promoter (Fig. 1B) . Thirty-one basepairs upstream of the transcription initiation site an AT-rich sequence is observed, which might serve as a TATA box (TATAAGA; Fig. 1B) . The sequence immediately upstream of the transcription initation site is extremely GCrich, including several consensus Spl binding sites, which implicates Spl in the expression of this gene. Whether these factors are important for the regulation of adipocyte-specific ob gene expression awaits further study. Sequence analysis identified a CAAT-like consensus C/EBP protein binding site at position -45 (TTGCGCAAG; Fig. 1B) .
In experiments designed to evaluate the tissue specificity of the ob promoter, a DNA fragment extending from about -3 kb to +30 bp relative to the transcription initiation site was inserted into the pGL3-Basic luciferase vector (Promega) to generate pGL3-OB1 (Fig. 24) . This vector was then transfected into primary rat adipocytes, mouse 3T3-L1, CV-1, and COS cells. Transfection efficiency of the various cell lines was monitored by evaluation of the activity of control vectors. Relative to the promoterless parent vector, the human ob promoter fragment stimulated luciferase expression up to 15-fold in primary rat adipocytes. In the 3T3-L1 cells maintained under nondifferentiating conditions, luciferase expression was 10-to 15-fold higher in the pGL3-OB1-transfected cells relative to the pGL3-Basic vector. In CV-1 cells, the same ob promoter fragment induced luciferase expression <2.5-fold (Fig. 2B) . Similar results were obtained with COS cells (data not shown). These results are consistent with the observation that ob mRNA expression is primarily observed in adipocytes and preadipocytes and suggest that the sequences necessary for pGL3-Basic :I -A-adipocyte lineage-specific expression of the ob gene are contained within these 3 kb.
To further define areas within this 3-kb region that are important for ob gene expression in adipocytes, a construct containing a 247-bp HindIII/KpnI fragment (spanning from positions -217 to +30), pGL3-OB2, was used to transfect primary rat adipocytes, 3T3-L1 and CV-1 cells. pGL3-OB2 had comparable promoter activity to pGL3-OB1 in adipocytes, while the expression in nonadipocyte lineages remained low (Fig. 2B ). The difference in expression level between adipocytes and cells from different origins suggests the existence of tissue-specific regulatory elements localized to the proximal 217 bp as evidenced by the robust expression of pGL3-OB2.
C/EBPei Determines the Activity of the Human ob Promoter in Vivo and in Vitro. Adipocyte differentiation has been shown to be determined by the coordinately acting transcription factors PPARy (23) and various members of the C/EBP family (21, 23, 24) among others. Having identified a potential binding site for C/EBP in the promoter, we examined its role in the expression of the ob gene. Cotransfection of a C/EBPa expression vector in primary rat adipocytes and 3T3-L1 preadipocytes induced ob promoter activity significantly. In primary rat adipocytes, expression of both the 3-kb promoter construct, pGL3-OB1, and the 217-bp construct, pGL3-OB2, were stimulated 2.5-to 4-fold (Fig. 3A) . In 3T3-L1 cells, C/EBPa cotransfection stimulated the expression of the two reporter vectors pGL3-OB1 and pGL3-OB2 by about 2.5-fold (Fig. 3B) . No significant effect was seen on the promoterless control. The upregulation of the pGL3-OB1 reporter vector in primary rat adipocytes by C/EBPa was concentrationdependent (Fig. 3C) . The fact that stimulation was seen with both the pGL3-OB1 and pGL3-OB2 constructs indicated that the consensus sequence contained within the 217 bp adjacent to the transcription initiation site was likely to be responsible for the increased luciferase expression. To further test this hypothesis, we mutated the consensus C/EBP site at nucleotide positions -53 to -45 from TTGCGCAAG to TTAAAA-AAG (mutant nucleotides underlined) in the pGL3-OB1 vector. When the mutant C/EBP construct pGL3-KOB1 was introduced into primary rat adipocytes, basal luciferase expression was reduced by more than 30% and the 2-fold stimulation of the wild-type promoter construct seen upon cotransfection with C/EBPa was absent, demonstrating that in the 3-kb promoter, this site was functional in mediating the effect of C/EBPa on ob gene expression (Fig. 4) . 
DISCUSSION
The association of murine obesity with mutations in the ob gene has generated intense interest in molecular studies aimed at delineating factors potentially involved in human obesity. In this study, we determined the structure of the human ob gene, identified potential regulatory elements in the promoter and demonstrated the role of an important adipocyte transcription factor, C/EBP in the expression of the ob gene. The human ob gene covers 15 kb of genomic DNA, previously mapped to chromosome 7p32 (22, 25) , and consists of three exons. Determination of the transcription initiation site by 5'-RACE, primer extension and Si nuclease protection are well correlated and confirm that the first small exon, containing only 5'-untranslated sequence, is located more than 10.5 kb upstream of the initiator codon.
The proximal promoter of the human ob gene contains a TATA-like sequence, GC-rich Spl-like sequences, as well as a C/EBP binding site and possible PPAR binding sites (PPREs). ob mRNA expression is restricted to the adipocyte. In this study we have demonstrated that as little as 217 bp of human ob gene upstream sequences are sufficient to drive high level, adipocyte-specific expression observed for the ob gene. The C/EBP site located within the proximal promoter was demonstrated to be functional and important for high level expression of the ob gene in preadipocytes and adipocytes. Indeed, mutation of the C/EBP site abolished the induction of the ob gene observed upon cotransfection of C/EBPa as well as modestly decreasing the basal level of expression.
The observation that ob gene expression is subject to transcriptional control by C/EBPa is consistent with the important role of C/EBPa in adipocyte differentiation. Arguments in support of a role of C/EBPa in adipogenesis comes from the temporal activation of C/EBPa expression just before the coordinate expression of a group of adipocyte genes (20) , the capacity of antisense C/EBPa RNA to inhibit adipocyte differentiation (26) , and the fact that premature induction or overexpression of C/EBPa triggers adipocyte differentiation (24, 27) . The important role of C/EBPa in adipogenesis was confirmed in mice in which the C/EBPa gene was disrupted by homologous recombination because the mutant mice failed to accumulate lipid in adipose tissue (28) . In addition to C/EBPa, C/EBPf3 and 6 are suggested to play an important transient role in early adipocyte differentiation by relaying the effects of hormonal stimulants such as glucocorticoids, insulin, and stimulators of the cAMP signaling pathways (29, 30 In conclusion, the structure of the human ob gene was determined and we have demonstrated physiologically relevant mechanisms by which the ob gene expression may be influenced, particularly by modulation of C/EBP levels or activity. The elucidation of the structure of the human ob gene will be useful for studies of mutations in this gene that may predispose to certain forms of obesity. Knowledge of sequence elements and factors regulating ob gene expression should furthermore be of major importance in the prevention and treatment of obesity.
Note: After submission of this manuscript, a report identifying C/EBPa sites in the mouse ob gene promoter was published (32) .
